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Abstract
Introduction:  Several  models  of  chronic  obstructive  pulmonary  disease  (COPD)  in mice have
been  developed;  the  most  similar  to  the  habit  of smoking  is the inhalation  of  the  smoke
in mice.  The  objective  was  to  develop  and  implement  an  experimental  model  of  COPD  in
mice through  the  passive  inhalation  of  smoke  and  demonstrate  the physiological  changes  on
ventilatory  function  and  its  correlation  with  3  emphysema  quantification  methods.
Materials and  methods: Twenty  Wistar  mice  were  included  in  an  experimental  and  control
group. The  experimental  group  was  exposed  to  tobacco  smoke,  and  we  performed  several
pulmonary  functional  tests  and  imaging  techniques.
Results:  Pulmonary  function  tests  showed  the  volume  expiration  in the first  second  (VEF1)
differs significantly  between  groups  (p  <  0.001).  Pulmonary  compliance  was  reduced  in the
experimental  group  by 50%  in  comparison  to  the control  group  (male  vs control  p  <  0.001).
Morphometric  analysis:  17%  reduction  in  lung  volume  with  a  destructive  index  (DI)  of  45%.  The
intersection test  had  a  DI of  43%.  The  free  point  test  showed  a  DI  of  44%.
Conclusions:  The  implementation  of  our model  generated  the  presence  of  emphysema  and
alterations  in  the  lung  physiology  in the  experimental  group.  We  demonstrated  evidence  of  90%
with emphysema.
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Introduction
Chronic  obstructive  pulmonary  disease  (COPD)  is  a  rising
health  problem  worldwide.  The  World Health  Organization
estimates  that  by  the year  2020  it  will  be  the  third  leading
cause  of  death  and the  fifth  most common  cause  of  dis-
ability,  and  to  this  date  there  are  no  therapies to  reduce
the  inevitable  progression  of  this disease.1 One  of  the  main
causes  of  COPD  is  inhalation  and/or  regular  exposure  to
tobacco  smoke.
Involuntary  exposure  to  tobacco  smoke  can  cause  signif-
icant  adverse  health  effects.2 In fact,  estimations  suggest
that  for  a  non-smoker,  involuntary  exposure  may  have  a
risk  equivalent  to  a  consumption  of  anywhere  from  4 to
10  cigarettes  a  day.3 The  reason  for this  is that  the  smoke
breathed  by  involuntary  or  passive  smokers  (a  person  who,
within  a  closed  environment,  inhales  tobacco  smoke  com-
ing  from  smokers)  contains  a far  higher  concentration  of
certain  toxic  components  than  the  smoke  breathed  directly
by  the  smoker  (person  who  has  smoked  any  amount  of
cigarettes  daily  for  the last  month).4 Alveolar  inflammation,
obstruction  and  destruction  are pathophysiological  changes
which  manifest  with  an increase  in airway  resistance,  the
lowering  of  oxygen diffusion  capacity,  deterioration  of the
ventilation--perfusion  relationship  and a  decrease  in pul-
monary  compliance.
Different  models  have  been  developed  to  explain  COPD’s
pathogenesis.  The  most important  one is  the inhalation  of
harmful  stimulus.  Different  animals,  such as  guinea  pigs,
rabbits,  dogs,  rats  and  mice  have  been  exposed  to  tobacco
smoke.  There  are  different  methods  for  tobacco  smoke
exposure,  such  as  through  a mask  or  body  chamber.5 The
results  obtained  with  this  model  are analyzed  with  phys-
iological  parameters  as  previously  stated  as  well  as  with
histopathological  analyses  such  as  the expansion  method,6,7
evaluation  methods  with  stained  cuts and  H&E  stain,  and
indirect  methods,  like the  fast  interval  processor.8,9
General objective
The  objective  of  this study was  the implementation  of
a  tobacco  smoke  passive inhalation  model  in  order  to
induce  emphysema,  prove  morphological  and  morphometric
changes  in  the  lungs  and  analyze  correlations  with  physi-
ological  variations  in  pulmonary  volumes.  Additionally,  the
three  tissue  loss  (emphysema)  quantification  methods  were
compared.
Materials  and  methods
The  study  included  20  Wistar  rats.  The  experimental  group
(EG)  consisted  of 5  males  and 6 females,  with  a weight  of
150  g  each  at the beginning  of the study.  The  rats  were  kept
in  stable  hosting  conditions,  in cages  with  an  ad  limitum
diet.  The  control  group  (CG)  was  made  up  of 6  males  and  3
females  were  paired  with  those  of  a similar  weight  to  those
in  the  EG  at the  end  of  the study.
A.  Exposure  to  tobacco  smoke:
The  Wistar  rats used  were  each  over  150  g,  6 weeks  old,
with  an  ad  limitum  diet.  Rats  in the EG  were  exposed  to
Burning chamber Exposure chamber       
Figure  1 Smoke  passes  from  the  burning  chamber  on  the  left,
to the  exposure  chamber  on  the  right.
the smoke  produced  by  the combustion  of  5 consecutive
cigarettes  with  filters  (Marlboro® red)  for  a  90  min  a  day,
5  days  a  week,  for a total  period  of  5  months.  The  expo-
sure  chamber  was  acrylic,  25  ×  25  ×  40  cm,  and  was  built
with  an upper  chimney  and  an orifice  in the lower  part
so  smoke  could  be introduced.  The  smoke  was  generated
in a combustion  chamber  formed  by  a  glass  jar  through
which  ambient  air was  constantly  pumped.  The  tobacco
smoke  was  conducted  through  a tube  toward the  base  of
the  box  (Fig.  1).
B.  Pulmonary  dynamic  measurement
Pulmonary  function  tests
(1)  Tidal  volume  (flow)  (TV)  and respiratory  frequency
(RF)  were  calculated  by  placing  the animal  in a
1.5-liter  plethysmograph  connected  through  a  MTL1
flow meter  to  a  spirometer  pod  and  using AID
instruments® Power  Lab  hardware.  After  calibrat-
ing  it  and spending  10  min  of  habituating,  they  were
registered  with  Chart  5 during  the next  15  min.
(2)  Forced  expiratory  volume  measurement  in the  first
second  (FEV1),  forced  vital capacity  (FVC),  and  max-
imum  expiratory  flow  were  performed  after  applying
anesthesia  with  pentobarbital  (50 mg/kg  intraperi-
toneally).  A metallic  stent  was  connected  to  the
flow  meter  through  a tracheotomy  and a three-way
connector  was  adapted  to the  other  opening  of  the
meter,  one opening  for  free  inhalation--exhalation
(I--E),  the  second  one connected  to  the  flow  meter
and  the third one  to  a  20-ml  syringe.  Normal  respira-
tions  were  registered  for  5  min,  and  a pentobarbital
overdose  was  administered.  When  the breathing
stopped  the I--E  way  was  occluded,  and  a volume
of  air  equivalent  to  5 times the  TV  was  injected,  this
was  calculated  using  the  formula  0.0062  ×  weight
(kg).  In  order  to  obtain  FEV1,  the abdomen  was
pressed  manually  using  half  the  distance  between
the  back  and rectum  as  a reference  point,  subse-
quently  it  was  released  via  I--E  simultaneously.  These
measurements  were  conducted  in  quadruplicate.
(3)  Since  the FEV1  percentage  in relationship  to  FCV
is  considered  in medical  literature  as  one  of the
most  important  variables  to  define  obstructive
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pathology,  these  percentages  were  obtained  in order
to  compare  them under  the following  parameters:
Mild  obstructive  alteration  (FEV1  60--80%),  moderate
FEV1 (40--59%)  and  advanced  FEV1 (≤39%).
(4)  Weight  variables  were  analyzed  through  ANOVA  tests
of  a  contrast  factor  with  the Scheffe  test  (non-
homogeneous  variances),  taking  p  <  0.05  to  be  a
significant  value.
Spirometry  variables  between  EG  and CG  (same
sex)  were  analyzed  through  the Student  t-test  for
independent  groups,  prior  to  a Levene  test  to  doc-
ument  the equality  of  variances.  In  the  case  of
FVC  and the  FEV1/FVC  relationship,  we  used  the
Mann--Whitney  U  test.
Pulmonary  compliance  and  tissue  preparation
(5) After  conducting  pulmonary  function  tests,  the tra-
cheal  cannula  was  connected  though  a  three-way
valve  to  a water  gauge,  the anterior  part  of  the
thorax  was  removed  and  volumes  of  5, 10,  15  and
20 ml  of physiological  solution  were  injected.  Water
pressure  during  inflation  was  quantified  in cm.
(6)  The  left lung  was  insufflated  with  formaldehyde  at
10%  until  reaching  a pressure  of  25  cm  of  water,
the  main  bronchi  was  occluded  and submerged  in
formaldehyde  at 10%  for  24  h,  and  was  subsequently
histologically  processed.
C.  Pulmonary  histology  and emphysema  quantification
Morphology  and  morphometry
Both  the  lungs  of  animals  exposed  to  tobacco  smoke
and  those  in the CG were  fixed  in  formaldehyde,  dehy-
drated,  washed  in toluene  and placed  in paraffin.
Histological  sections  of  5 microns  of thickness  were  per-
formed  and  stained  with  hematoxylin,  eosin  and  the
Wilder  method  for  reticular  fibers;  morphologic  and  mor-
phometric  evaluations  were then  conducted.
Morphometric  analysis:
(A)  Pulmonary  tissue  particle  analysis:
(1)  Capture:  Images  at  4×  of the  entire  lung  were  taken
using  an Olympus  BX41  microscope,  and  an Olympus
SP-350  digital  camera  with  a  32  MB memory  card.
The  pictures  were  stored  in a  Pentium  4 IBM  com-
puter.
(2)  Processing:  A  total  of 52  images  of  each lung  were
obtained.  Subsequently,  these images  were  com-
bined  using  Adobe  Photoshop,  forming  a single
image  or  the entire  lung.
(3) Image  analysis:  The  application  ImageJ  by  Tony
Collins,  PhD  was  used.  The  images  were  converted
to  8-bit, then,  through  a  ‘‘Rolling  ball’’  algorithm,
the  background  of the image  was  removed,  thus
obtaining  a clearer  image  without shadows.  Lastly,
the  image  was  converted  to  black  and  white.  Once
this process  was  performed  and,  using  particle  anal-
ysis,  we  obtained  the percentage  of  tissue  (Fig.  2).
(B)  Destructive  index  analysis  using  acetates  with  50  count-
able  dots.
(1)  Image  selection:  Images  free  of  large  bronchioles,
vessels,  collapsed  tissue  or  extensive  fibrosis  were
obtained.
(2)  An  acetate  with  50  countable  dots  was  used,  which
was  placed  over the computer  screen.  The  latter
showed the images  of  the  tissues  configured  (in  size
A5)  in  relationship  to the  size  of the acetate  (Fig.  2).
(3)  Destruction  was  defined  based  on  one  or  two  of  the
following  criteria:  (a)  at least  two  defects  on  the
alveolar wall,  (b)  at least two  intersections  with
intramural  parenchymal  tissue  in the  alveolar  ducts,
(c)  clear  abnormal  morphology  or  (d)  classic  emphy-
sematous  changes.
(4) The  total  amount  of dots counted  was  divided
between  the  total  area of  each lung,  thus obtain-
ing  the  area/dots  ratio  and  an  average.  The  results
were  included  in the  formula  to  calculate  the
destructive  index  [D/(D  +  N)]  ×  100%,  where D  =  dots
where  there  are  tissue  defects  compatible  with
those  described  in the last section  and  N = dots
where  there  is  normal  tissue10 (Fig.  2).
(C) Line  intersection  analysis.11
(1)  Image  selection:  Images  free  of  large  bronchioles,
vessels,  collapsed  tissue  or  extensive  fibrosis  were
obtained.  The  same  images  used  in the destructive
index  analysis  with  50  dots were  used for  the  alve-
olar  wall  intersection  analysis.
(2)  A  horizontal  acetate  with  50  horizontal  lines  was
placed  over the computer  screen,  where  we  were
able  to  see  the  images  of  the tissue  configured  (in
size  A5)  in relationship  to  the size  of  the acetate.
Figure  2  Image  analysis.  Measurement  of  the destructive  index  with  point  intersection  (left)  and  line  intersection  (right).
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Table  1  Pulmonary  function  tests.
Male  Female
CONTROL  COPD  p* CONTROL  COPD  p*
Weight  395.6  ± 49.2  385.8  ±  18.7  0.68  262.3  ±  15.6  214.5  ± 20.9  0.01
TV 1.03  ± 0.23  0.63  ±  0.77  0.26  0.56  ±  0.43  0.56  ± 0.74  0.99
RF 124.6  ± 36.8  52.3  ±  24.4  0 105.5  ±  26.8  35.0  ± 41.6  0.03
FVC 10.4  ± 1.5  6.8  ±  4.4  0.15  7.1  ±  0.8  5.8  ± 6.9  0.77
FEV1 8.6 ± 1.3  1.4  ±  1.1  0 6.1  ±  0.8  1.6  ± 1.8  0
FEV/FVC 82.5  ± 12.3 25.3  ±  15.5 0 86.2  ±  2.1  49.7  ± 37.5  0.06
PEF 4.5 ± 2.2 9.3  ±  8.1 0.24 20.6  ±  14.3 17.68  ± 9.8 0.76
* p: probability associated with the Student t-test controls vs experimentals.
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Graph  1  Volume  pressure  curves  for  males  (right)  and  females  (left).  In  each  graph,  the  control  group  is shown  on  the  left  and
the experimental  group  is shown  on  the right.
(3)  Images  of bronchi,  large  bronchioles,  blood  vessels
and  collapsed  tissue  were  excluded  for measure-
ment.
(4)  The  total  amount  of intersections  counted  was
divided  between  the total  area  of  each lung, thus
obtaining  the  area/lines  ratio  and  an average.  The
results  were  included  in the  formula  to  calculate
the  destructive  index.
Results
Pulmonary  dynamic  measurement/pulmonary
function  tests
The  comparison  between  EG  and  CG  by  gender  showed  sim-
ilarities  between  TV,  peak expiratory  flow  (PEF)  and FCV.
RF  and  FEV1/FCV  between  controls  and experimental  males
differed  significantly.
FEV1  differed  significantly  between  both  groups
(Table  1). In the  EG,  FEV1  showed a severe  alteration  in
81.8%  of  the animals.  9.1% of  the animals  presented  a
mild  alteration  and the remaining  9.1%  did  not  present
anomalies.
The  affection  rate  of FEV1  in  animals  with  altered
results
Pulmonary  compliance  decreased  in EG,  in  both  genders,
proven  by  the reduction  in  the slope  of  the  pressure--volume
graph  (Graph  1).
84.00
80.00
76.00
72.00
Experimental
Lu
ng
 ti
ss
ue
 p
er
ce
nt
ag
e
Control
Graph  2 Lung  tissue  percentage  assessed  by  particle
analysis.
Morphometric  analysis:
(1)  Particle  analysis
There  was  a  reduction  in the  experimental  group’s
percentage  of  cellular  tissue,  from  23.5%  to  19.44%,
which  reflects  that there  was  a  loss  of  17.3%  of  the  tis-
sue,  when  considering  that  the lung  of  the control  group
Documento descargado de http://www.elsevier.es el 25-08-2016
Emphysema  model  in rats  exposed  to  tobacco  smoke  83
is  100%.  The  control  group  had a standard  deviation  of
4%  and  the experimental  group  2.7% (Graph  2).
The  average  size  of the tissue  (in mm2)  in  the  lungs
of  the  control  group  was  8.9 mm2, and  was  7.47  mm2 in
the  experimental  group.  This  translates  to  an average
loss  of  1.5  mm2 of  tissue  in  the experimental  group.  The
destructive  index  was  calculated  at 45.3%.
(2)  Lines  and  dots  intersection
The  result  of  the area/lines  index  in  the  lungs  of  the
CG  was  0.014,  and  0.011  for  the EG.  This  is  reflected
as  a  21.4%  tissue  loss  in the lungs  of  the EG,  taking  into
account  that  the  lungs  in the CG  represent  100%.  The
calculated  destructive  index  was  43.6%,  with  100% being
total  destruction.
The  result  of  the area/dot  index  in  the lungs  of  the
CG was  0.022  and 0.018  in  the  lungs  of the  EG. This
is a  tissue  loss  of  18.19%  in  the lungs  of  the  EG. The
calculated  destructive  index  was  44.8%.
Pearson  correlation  between  the results  of both  the
lines  and  dots  tests  gave  us r = 0.576,  p  < 0.05.  This
proves  that  both  tests  are valid  to  use  in  the morpho-
metric  analysis  of  pulmonary  tissue.
Discussion
The implementation  of  a tobacco  smoke  inhalation  model
is  the  closest  to  the  habit of  smoking.  Physiological  find-
ings  identified  in  this  model  partially  match  with  published
results  of  other  models  like  the degradative  enzyme  instil-
lation  and  genetic  modification  techniques,  as  well  as  with
other  harmful  stimuli  inhalation  models.12 Unlike  previously
described  models,  we  were  able  to  observe  that  in our
tobacco  smoke  inhalation  model  COPD-type  lesions  were
generated  and,  even  though  it was  a  slow  process,  it  was  an
easy  and  cheap  one  compared  to  other  more  sophisticated
and  costly  models.
There  is  no  doubt  that the  COPD  induction  model  based
on  inhalation  of tobacco  smoke  is  the closest  to  the pro-
cess  that  the  habit  of smoking  causes  in  humans.  Taking  into
consideration  the design  and application  of the  model,  it
was  proven  that  passive  exposure  to  tobacco  smoke  is  sig-
nificant  in  the  development  of this  pathology.  Studies  which
use  biological  markers  such  as  cotinine  report  significant  lev-
els  of  environmental  nicotine  in the homes  of  smokers.13
The  relevance  lies  in  the  fact that  there  are over  400  iso-
lated  substances  of  cigarette  smoke,  some of  which  have
carcinogenic  potential,  like  lead  and  polonium.14
Approximately  half  of all  smokers  have  an early  death
caused  by  diseases  linked  to  smoking.15 The  existing  rela-
tionship  between  smoking  and  the different  types  of  cancer
or  cardiovascular  diseases  has  been  proven.16,17 For  exam-
ple,  a  50  year  study  on  health effects  in British  doctors
showed  that  a doctor  who  was  35  years  old or  older  who
smoked  had  a life  expectancy  of  approximately  10  years  less
than  those  who  never  smoked.
Because  of  the relative  risks  of  suffering  adverse  health
effects  by  being a  passive  smoker  are  much  lower,  they
are  less  tangible  than  those  of  an active smoker.  Studies,
however,  have  proven  correlations  between  passive  smoking
and  a  number  of  diseases,  including  lung  cancer  and  heart
disease.18
A meta-analysis  of  37  epidemiological  studies  of  lung  can-
cer  found  a relative  risk  (RR)  of  lung  cancer  of 1.24,  with  a
confidence  interval  (CI)  of  95%,  in non-smokers  who  lived
with  a  smoker,  compared  to  non-smokers  who lived  with
non-smokers.19
Another  meta-analysis  of  19  published  studies  showed  a
relative  risk  of  heart  disease  of  1.23,  with  a CI of  95%,  in
non-smokers  who  lived  with  a  smoker  versus  non-smokers
who  did not.20
Estimations  suggest  that  in the US,  there  are  60,460
deaths  of  passive  smokers  a year, versus  47,000  deaths  by
heart  disease,  3060  by  lung  cancer  and  10,400  of  other
cancers.21 A study  of  ischemic  heart  disease  estimated  a
mortality  risk  for the  non-smoker  who  lives with  a smoking
partner  is  2.2%  for  men  and  1.2% for women  (RR  assumed
for  heart  disease:  1.31  and  1.24,  respectively).22
Alveolar  inflammation,  obstruction  and  destruction  are
pathophysiological  changes  that manifest  with  a rise  in air-
way  resistance,  a  reduction  of  the capacity  for  oxygen
diffusion,  deterioration  of  the  ventilation--perfusion  rela-
tionship  and a  decrease  in  pulmonary  compliance.  Research
of  functional  parameters,  while  still  controversies  in the
study  of this pathology,  reports  values  which  are the base
for  its  own  diagnosis.  In  this  model,  we  are able  to  find
from  the studied  parameters  that  the greatest  objective
to corroborate  an obstructive  pathology  is  the reduction
of  FEV1,  since,  in  the other  major  parameters  reported  in
other  studies,23 FVC  and FEV1/FVC  did not show  statistically
significant  differences  between  groups.  In  fact,  FCV  does
not differ  in any  of the  groups,  in  both  males  and  females
the  FEV1/FVC  relationship  differs  only  amongst  male  COPD
versus  controls,  which  leaves  them  out of  the criteria  to
include  them  as  an objective  parameter  in the model.  There
is  current  evidence  that  females  tend  to  develop  emphy-
sema  before  males  do.  In our  study,  it may  be due  to  an
insufficient  sample  size.24
During the pathological  process of emphysema,  the elas-
tic  pulmonary  tissue  is  destroyed  by  different  mechanisms,
which  reduces  pulmonary  compliance  and  provokes  the  lungs
to  resist  volume  pressure  changes  less.  We  found  that  the
COPD groups  (males  and females)  showed  a reduction  in
pulmonary  compliance  according  to  the pressure--volume
charts,  which  agrees  with  the  alterations  described  by  other
authors.25,26 This  allows  us  to  consider  pulmonary  compli-
ance  as  a major  indicator  in this  model.
Only  9.1%  of  the animals  did not  develop  emphysema,
possibly  due  to  a  genic  polymorphism.  In the  morphological
analysis  by  dot intersection,  which  is  a  technique  used  to
quantify  the increase  in the  alveolar  space size, a  greater
pulmonary  parenchymal  destruction  was  proven.  As  with  the
intersection  with  lines,  this  is  a semi-quantitative  test  tar-
geted  to  assess  parenchymal  destruction.  A more  specific
test  would  be  particle  analysis,  which  is  a  computerized
technique  based on  pixel  counting  in digital  images,  thus
finding  out  the  cellular  percentage.  This  is  the most  spe-
cific  technique  to  assess  changes  that  occur  in pathologies
where  there  is loss  of  the  parenchyma;  therefore,  it  is  the
most recommended.
One  of  the  limitations  of  the study  is  that  we  did  not
measure  the  carboxyhemoglobin  or  cotinine  levels  for  an
accurate  measurement  of tobacco  smoke  exposure  as  other
studies  have  done.
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The  developed  COPD  model  showed pathophysiologic
results  characteristic  of  emphysema,  such as  the  destruction
of  the  alveolar  walls.  The  marked  reduction  in pulmonary  tis-
sue,  which  translates  to  parenchymal  destruction  of  the EG,
demonstrates  the effect  of  tobacco  smoke  in the production
of  COPD.  This  proves  the  important  relationship  between
morphology  and ventilator  function.
Conclusions
The  implementation  of  our model  created  the presence  of
emphysema  and  pulmonary  physiological  alterations  in the
experimental  group.
Based  on  our  results,  we  are able  to  conclude  that
there  is  a  strong  correlation  between  histopathological  stud-
ies  and  those  which  assess  pulmonary  function  since,  from
the  animals  which  presented  emphysema  demonstrated  by
pathology,  90%  presented  alterations  in the pulmonary  func-
tion  tests.
The  three  methods  used  to quantify  tissue  loss,  the  par-
ticle  analysis  and  dot  and line  intersection,  are  effective
in  the  assessment  of  emphysema.  Nevertheless,  out  of  the
three,  the  method  which is  the easiest  to  apply  is  the
particle  analysis,  since  one  of  its advantages  is  that  it is
automatic.  Also,  its  assessment  is  through  computer  soft-
ware.  However,  this  can  turn  out to be  a  limitation  as  well.
Regarding  the other  two  methods,  they have  the advantage
that  their  technique  is simple,  yet  they take  a  long  time  and
their  application  is  too  elaborate.
The correlation  between  lines  and  dots  intersection  test
results  show  that  both  are  valid  tests  to  use  in the  morpho-
metric  analysis  of  pulmonary  tissue.
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